Follow
Dongbo Xu
Title
Cited by
Cited by
Year
Natural products from mangrove actinomycetes
DB Xu, WW Ye, Y Han, ZX Deng, K Hong
Marine drugs 12 (5), 2590-2613, 2014
1832014
Bioprospecting deep-sea actinobacteria for novel anti-infective natural products
D Xu, L Han, C Li, Q Cao, D Zhu, NH Barrett, D Harmody, J Chen, H Zhu, ...
Frontiers in microbiology 9, 787, 2018
372018
Nocardiopsistins AC: New angucyclines with anti-MRSA activity isolated from a marine sponge-derived Nocardiopsis sp. HB-J378
D Xu, KK Nepal, J Chen, D Harmody, H Zhu, PJ McCarthy, AE Wright, ...
Synthetic and Systems Biotechnology 3 (4), 246-251, 2018
322018
Halichoblelide D, a New Elaiophylin Derivative with Potent Cytotoxic Activity from Mangrove-Derived Streptomyces sp. 219807
Y Han, E Tian, D Xu, M Ma, Z Deng, K Hong
Molecules 21 (8), 970, 2016
242016
PreQ0 base, an unusual metabolite with anti-cancer activity from Streptomyces qinglanensis 172205
D Xu, M Ma, Y Liu, T Zhou, K Wang, Z Deng, K Hong
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2015
192015
Genotype-driven isolation of enterocin with novel bioactivities from mangrove-derived Streptomyces qinglanensis 172205
DB Xu, M Ma, ZX Deng, K Hong
Applied microbiology and biotechnology 99, 5825-5832, 2015
132015
Identification of a novel lincomycin resistance mutation associated with activation of antibiotic production in Streptomyces coelicolor A3 (2)
G Wang, M Izawa, X Yang, D Xu, Y Tanaka, K Ochi
Antimicrobial agents and chemotherapy 61 (2), e02247-16, 2017
122017
Bioactive Molecules from Mangrove Streptomyces qinglanensis 172205
D Xu, E Tian, F Kong, K Hong
Marine Drugs 18 (5), 255, 2020
112020
Uncovering Lasonolide A biosynthesis using genome-resolved metagenomics
S Uppal, JL Metz, RKM Xavier, KK Nepal, D Xu, G Wang, JC Kwan
Mbio 13 (5), e01524-22, 2022
82022
Inhibitory effect of a novel histone deacetylases inhibitor FK228 on human colon cancer HCT-116 cells in vitro and in vivo
DB Xu, YL Wang, Y Yue, SC Wu, H Ding
Zhonghua Zhong liu za zhi [Chinese Journal of Oncology] 35 (11), 814-818, 2013
52013
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.
D Xu, Q Cao, L Wang, J Wang, B Xu, K Atwood, L Wei, Y Wu, GJ Smith, ...
Molecular Cancer Therapeutics, 2022
42022
Brominated and sulfur-containing angucyclines derived from a single pathway: identification of nocardiopsistins D–F
D Xu, J Metz, D Harmody, T Peterson, P Winder, EA Guzmán, R Russo, ...
Organic Letters 24 (43), 7900-7904, 2022
32022
Ex Vivo Organoid Model of Adenovirus-Cre Mediated Gene Deletions in Mouse Urothelial Cells
D Xu, L Wang, K Wieczorek, Y Wang, X Zhang, DW Goodrich, Q Li
JoVE (Journal of Visualized Experiments), e63855, 2022
32022
Single-cell analyses of a novel mouse urothelial carcinoma model reveal a role of tumor-associated macrophages in response to anti-PD-1 therapy
D Xu, L Wang, K Wieczorek, Y Zhang, Z Wang, J Wang, B Xu, PK Singh, ...
Cancers 14 (10), 2511, 2022
22022
Genome Sequence of Streptomyces sp. Strain HB-N217, Isolated from the Marine Sponge Forcepia sp
RKM Xavier, D Xu, PJ McCarthy, S Yang, G Wang
Microbiology Resource Announcements 10 (8), 10.1128/mra. 01410-20, 2021
22021
MP14-12 MODELING IMMUNOTHERAPY RESISTANCE OF BLADDER CANCER IN IMMUNOCOMPETENT MICE
D Xu, L Wang, K Wieczorek, B Xu, D Goodrich, Q Li
The Journal of Urology 209 (Supplement 4), e187, 2023
2023
MP06-09 SINGLE CELL ANALYSES OF MURINE UROTHELIAL CARCINOMA CELLS REVEAL A ROLE OF TUMOR-ASSOCIATED MACROPHAGES IN RESPONSE TO ANTI-PD1 THERAPY
D Xu, L Wang, Y Zhang, Y Wang, X Zhang, Y Wu, G Smith, B Xu, P Singh, ...
The Journal of Urology 207 (Supplement 5), e80, 2022
2022
Abstract B13: A novel mouse model for small-cell carcinoma of bladder
D Xu, Q Cao, L Wang, Y Wang, X Zhang, Y Wu, G Smith, B Xu, ...
Cancer Research 80 (11_Supplement), B13-B13, 2020
2020
MP01-10 A NOVEL MOUSE AND ORGANOID MODEL FOR SMALL CELL CARCINOMA OF BLADDER
D Xu*, Q Cao, L Wang, Y Wang, Y Wu, X Zhang, G Smith, B Xu, ...
The Journal of Urology 203 (Supplement 4), e5-e5, 2020
2020
MP51-16 SPIRONOLACTONE, A NUCLEOTIDE EXCISION REPAIR INHIBITOR, POTENTIATES CYTOTOXIC EFFECT OF CISPLATIN IN BLADDER CANCER CELLS
D Xu*, L Wang, Y Wu, G Smith, E Kauffman, J Mohler, D Goodrich, Q Li
The Journal of Urology 201 (Supplement 4), e729-e730, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20